The Development of Oral Therapeutic Vaccine against Cancer and Working out on the Fast Testing of Immunogenic and Oncolytic Effector Antigens
<p id="p1">In the study of “the herd immunity”, it was found that antigenic “late” proteins L1 of human papillomavirus of types 6,16,18,31 and 45, “early” proteins E2, E6 and E7 induced the generation of interferon, CD4/CD8 T lymphocytes and T cell receptors, as w...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1136342 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: The Development of Oral Therapeutic Vaccine against Cancer and Working out on the Fast Testing of Immunogenic and Oncolytic Effector Antigens
- Approaches to Improve the Immunogenicity of Plasmid DNA-Based Vaccines against COVID-19
- Immunogenicity Prediction with Dual Attention Enables Vaccine Target Selection
- The Experience in Planting <i>Solanum lycopersicum</i>: Organic Cultivation in East Siberia, Transgenesis and the Connection with Plasticity of Tomato Genome Expression
- Salmonella as Live Carrier of Antigens in Vaccine Development
- Evaluating the immunogenic potential of BAX protein isoforms as therapeutic targets in oncology: brief report
- A Review of COVID-19 Vaccines, Immunogenicity, Safety, and Efficacy toward Addressing Vaccine Hesitancy, Inequity, and Future Epidemic Preparedness